Holly Elizabeth Rawizza

Biography

Publications

• Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy.

  Semere Gebreyesus M, Wasmann RE, McIlleron H, Oladokun R, Okonkwo P, Wiesner L, Denti P, Rawizza HE. Antimicrob Agents Chemother 2024 Aug 07

• Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria.

  Ebonyi AO, Okpokwu J, Rawizza H, Chebu P, Chaplin B, Hamel D, Oguche S, Agbaji OO, Sagay AS, Kanki PJ, Imade GE. Open Forum Infect Dis 2024

• Bone Mineral Density and Vitamin D Status in Nigerians: The Impact of HIV.

  Abene EE, Gimba ZM, Rawizza H, Odoh G, Amusa GA, Chundusu DY, Imoh LC, Agaba EI, Sagay SA. West Afr J Med 2023 04 28

• Timeliness of Point-of-Care Viral Load Results Improves Human Immunodeficiency Virus Monitoring in Nigeria.

  Chaplin B, Agbaji O, Reyes Nieva H, Olatunde B, Chang C, Mitruka K, Sule H, Dajel T, Zee A, Ahmed ML, Ahmed I, Okonkwo P, Rawizza H, Kanki P. Clin Infect Dis 2023 02 08

• Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART.

  Rawizza HE, Oladokun R, Ejeliogu E, Oguche S, Ogunbosi BO, Agbaji O, Odaibo G, Imade G, Olaleye D, Wiesner L, Darin KM, Okonkwo P, Kanki PJ, Scarsi KK, McIlleron HM. J Antimicrob Chemother 2021 02 11